Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Research and Practice in Thrombosis and Haemostasis|November 17, 2025
FRONTIER1 multiple ascending dose extension: a safety, tolerability, pharmacokinetics, and pharmacodynamics study of Mim8 in people with hemophilia APratima Chowdary, Steven R Lentz, Lidia Gil, et al.
Thrombosis and Haemostasis|August 22, 2015
Inhibitor development in non-severe haemophilia across EuropeKathelijn Fischer, Alfonso Iorio, Riitta Lassila, et al.
Therapeutic Advances in Hematology|July 19, 2023
Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: post hoc subanalysis of the randomized, phase 3 PROPEL studyCarmen Escuriola-Ettingshausen, Robert Klamroth, Miguel Escobar, et al.
Therapeutic Advances in Hematology|August 2, 2023
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) studyCarmen Escuriola Ettingshausen, Cedric Hermans, Pål A Holme, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 21, 2020
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia BJerzy Windyga, Margarita Timofeeva, Oleksandra Stasyshyn, et al.
Advances in Therapy|April 18, 2023
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient PopulationsImre Bodó, Ismail Amine, Ana Boban, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 10, 2024
Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with InhibitorsBülent Zülfikar, Johnny Mahlangu, Salim Mohamed Nekkal, et al.
Blood|November 5, 2020
Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL studyRobert Klamroth, Jerzy Windyga, Vlad Radulescu, et al.
European Journal of Internal Medicine|May 9, 2026
Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control studyKrzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, et al.
European Journal of Haematology|September 10, 2015
Managing Haemophilia for Life: 5th Haemophilia Global SummitCedric Hermans, Gerry Dolan, Ian Jennings, et al.
Pageof 10